SAMPLE. North America Propylene Industry Outlook to 2017 GDCH0615RDB/JAN 2013

Size: px
Start display at page:

Download "SAMPLE. North America Propylene Industry Outlook to 2017 GDCH0615RDB/JAN 2013"

Transcription

1 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Reference Code: GDCH0615RDB Publication Date: January 2013 GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 1

2 1 Table of Contents 1 Table of Contents List of Tables List of Figures 8 2 North America Propylene Industry, Supply Scenario, North America Propylene Industry, Total Plant Capacity, North America Propylene Industry, Installed Plant Capacity by Key Feedstock, North America Propylene Industry, Installed Plant Capacity by Production Process, North America Propylene Industry, Installed Plant Capacity by Technology, North America Propylene Industry, Company Share, North America, Propylene Industry, Planned Projects Details, North America Propylene Industry, Market Dynamics, North America Propylene Industry, Market Size, North America Propylene Industry, Demand and Production Outlook, North America Propylene Industry, Demand by End Use Sector, North America Propylene Industry, Price Forecasts, The US Propylene Industry The US Propylene Industry, Supply Scenario, The US Propylene Industry, Total Plant Capacity, The US Propylene Industry, Installed Plant Capacity by Key Feedstock, The US Propylene Industry, Installed Plant Capacity by Production Process, The US Propylene Industry, Installed Plant Capacity by Technology, The US Propylene Industry, Company Share, The US, Propylene Industry, Planned Projects Details, The US Propylene Industry, Market Dynamics, The US Propylene Industry, Market Size, The US Propylene Industry, Demand and Production Outlook, The US Propylene Industry, Demand by End Use Sector, The US Propylene Industry, Price Forecasts, The US Propylene Industry, Trade Balance, The US Propylene Industry, Imports and Exports, The US Propylene Industry, Net Exports, The US Propylene Industry, Imports as Percentage of Demand, Canada Propylene Industry 96 GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 2

3 4.1 Canada Propylene Industry, Supply Scenario, Canada Propylene Industry, Total Plant Capacity, Canada, Propylene Industry, Planned Projects Details, Canada Propylene Industry, Market Dynamics, Canada Propylene Industry, Market Size, Canada Propylene Industry, Demand and Production Outlook, Canada Propylene Industry, Demand by End Use Sector, Canada Propylene Industry, Price Forecasts, Canada Propylene Industry, Trade Balance, Canada Propylene Industry, Imports and Exports, Canada Propylene Industry, Net Exports, Canada Propylene Industry, Imports as Percentage of Demand, LyondellBasell Industries N.V., Company Snapshot LyondellBasell Industries N.V., Company Overview LyondellBasell Industries N.V., Key Information LyondellBasell Industries N.V., Business Description Business Overview LyondellBasell Industries N.V., Propylene Market, LyondellBasell Industries N.V., Propylene Capacity Split, North America and Rest of the World, LyondellBasell Industries N.V., Propylene Plant Capacity Share in North America, LyondellBasell Industries N.V., Propylene Capacity in North America, LyondellBasell Industries N.V., Propylene Plant Details in North America, SWOT Analysis Overview LyondellBasell Industries N.V. Strengths LyondellBasell Industries N.V. Weaknesses LyondellBasell Industries N.V. Opportunities LyondellBasell Industries N.V. Threats Exxon Mobil Corporation, Company Snapshot Exxon Mobil Corporation, Company Overview Exxon Mobil Corporation, Key Information Exxon Mobil Corporation, Business Description Business Overview Chemical Downstream 127 GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 3

4 6.3.4 Upstream Exxon Mobil Corporation, Propylene Market, Exxon Mobil Corporation, Propylene Capacity Split, North America and Rest of the World, Exxon Mobil Corporation, Propylene Plant Capacity Share in North America, Exxon Mobil Corporation, Propylene Capacity in North America, Exxon Mobil Corporation, Propylene Plant Details in North America, SWOT Analysis Overview Exxon Mobil Corporation Strengths Exxon Mobil Corporation Weaknesses Exxon Mobil Corporation Opportunities Exxon Mobil Corporation Threats Royal Dutch Shell plc, Company Snapshot Royal Dutch Shell plc, Company Overview Royal Dutch Shell plc, Key Information Royal Dutch Shell plc, Business Description Business Overview Corporate Downstream Upstream Royal Dutch Shell plc, Propylene Market, Royal Dutch Shell plc, Propylene Capacity Split, North America and Rest of the World, Royal Dutch Shell plc, Propylene Plant Capacity Share in North America, Royal Dutch Shell plc, Propylene Capacity in North America, Royal Dutch Shell plc, Propylene Plant Details in North America, SWOT Analysis Overview Royal Dutch Shell plc Strengths Royal Dutch Shell plc Weaknesses Royal Dutch Shell plc Opportunities Royal Dutch Shell plc Threats Appendix Definitions Installed Plant Capacity Key Feedstock Process Technology Abbreviations 154 GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 4

5 8.3 GlobalData s Methodology Coverage Secondary Research Primary Research Expert Panel Validation Disclaimer List of Tables Table 1: North America, Total Propylene Plant Capacity, MMTPA, Table 2: Propylene Industry, Total Plant Capacity by Region, MMTPA, Table 3: North America, Major Propylene Plants Capacity, MMTPA, Table 4: North America, Major Propylene Plants Capacity, MMTPA, (Contd.) 13 Table 5: North America, Major Propylene Plants Capacity, MMTPA, (Contd.) 14 Table 6: North America, Major Propylene Plants Capacity, MMTPA, (Contd.) 15 Table 7: North America, Major Propylene Plants Capacity, MMTPA, (Contd.) 16 Table 8: North America, Major Propylene Plants Capacity, MMTPA, (Contd.) 17 Table 9: North America, Major Propylene Plants Capacity, MMTPA, (Contd.) 18 Table 10: North America, Active Propylene Capacity Share by Country, %, Table 11: North America, Active Propylene Plants Share by Country, %, Table 12: North America, Major Active Propylene Plant Details, MMTPA, Table 13: North America, Major Active Propylene Plant Details, MMTPA, 2012 (Contd.) 23 Table 14: North America, Major Active Propylene Plant Details, MMTPA, 2012 (Contd.) 24 Table 15: North America, Major Active Propylene Plants by Key Feedstock, Production Process and Technology, Table 16: North America, Major Active Propylene Plants by Key Feedstock, Production Process and Technology, 2012 (Contd.) 25 Table 17: North America, Major Active Propylene Plants by Key Feedstock, Production Process and Technology, 2012 (Contd.) 26 Table 18: North America, Major Active Propylene Plants by Key Feedstock, Production Process and Technology, 2012 (Contd.) 27 Table 19: North America, Top Propylene Plants Capacity, %, Table 20: North America, Top Propylene Plant Details, Table 21: North America Propylene Industry, Installed Plant Capacity by Key Feedstock, Table 22: North America, Propylene Industry, Installed Plant Capacity by Naphtha, Table 23: North America, Propylene Industry, Installed Plant Capacity by Naphtha, 2012 (Contd.) 30 Table 24: North America, Propylene Industry, Installed Plant Capacity by Natural Gas, Table 25: North America, Propylene Industry, Installed Plant Capacity by Natural Gas, 2012 (Contd.) 31 Table 26: North America Propylene Industry, Installed Plant Capacity by Production Process, Table 27: North America, Propylene Industry, Installed Plant Capacity by Fluid Catalytic Cracking, Table 28: North America, Propylene Industry, Installed Plant Capacity by Steam Cracking, Table 29: North America, Propylene Industry, Installed Plant Capacity by Olefin Metathesis, Table 30: North America, Propylene Industry, Installed Plant Capacity by Deep Catalytic Cracking, Table 31: North America, Propylene Industry, Installed Plant Capacity by Propane Dehydrogenation, Table 32: North America Propylene Industry, Installed Plant Capacity by Technology, GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 5

6 Table 33: North America, Propylene Industry, Installed Plant Capacity by CB&I Lummus (OCT) Propylene Technology, Table 34: North America, Propylene Industry, Installed Plant Capacity by Linde AG Propylene Technology, Table 35: North America, Propylene Industry, Installed Plant Capacity by KBR Superflex Propylene Technology, Table 36: North America, Propylene Industry, Installed Plant Capacity by Stone & Webster Propylene Technology, Table 37: North America, Propylene Industry, Installed Plant Capacity by CB&I Lummus (Catofin) Propylene Technology, Table 38: North America, Propylene Industry, Installed Plant Capacity by Company, %, Table 39: North America, Propylene Industry, Planned Projects, Table 40: North America, Propylene Industry, Demand Value, $bn, Table 41: Propylene Industry, Demand Value Growth by Region, $bn, Table 42: North America, Propylene Industry, Demand and Production, MMTPA, Table 43: Propylene Industry, Demand by Region, MMTPA, Table 44: Propylene Industry, Production by Region, MMTPA, Table 45: North America, Propylene Industry, Production by Country, %, Table 46: North America, Propylene Industry, Demand by Country, %, Table 47: North America, Propylene Industry, Demand by End Use Sector, %, Table 48: Propylene Industry, End Use by Regions, MMTPA, Table 49: North America, Propylene Industry, Price Forecasts, $/Tonne, Table 50: Propylene Industry, Average Price by Region, $/Tonne, Table 51: The US, Total Propylene Plant Capacity, MMTPA, Table 52: The US, Propylene Plants Capacity, MMTPA, Table 53: The US, Propylene Plants Capacity, MMTPA, (Contd.) 57 Table 54: The US, Propylene Plants Capacity, MMTPA, (Contd.) 58 Table 55: The US, Propylene Plants Capacity, MMTPA, (Contd.) 59 Table 56: The US, Propylene Plants Capacity, MMTPA, (Contd.) 60 Table 57: The US, Propylene Plants Capacity, MMTPA, (Contd.) 61 Table 58: The US, Propylene Plants Capacity, MMTPA, (Contd.) 62 Table 59: The US, Propylene Plants Capacity, MMTPA, (Contd.) 63 Table 60: The US, Active Propylene Plants by State, %, Table 61: The US, Active Propylene Plant Details, MMTPA, Table 62: The US, Active Propylene Plant Details, MMTPA, 2012 (Contd.) 66 Table 63: The US, Active Propylene Plant Details, MMTPA, 2012 (Contd.) 67 Table 64: The US, Active Propylene Plants by Key Feedstock, Production Process and Technology, Table 65: The US, Active Propylene Plants by Key Feedstock, Production Process and Technology, 2012 (Contd.) 68 Table 66: The US, Active Propylene Plants by Key Feedstock, Production Process and Technology, 2012 (Contd.) 69 Table 67: The US, Active Propylene Plants by Key Feedstock, Production Process and Technology, 2012 (Contd.) 70 Table 68: The US, Top Propylene Plants Capacity, %, Table 69: The US, Top Propylene Plant Details, Table 70: The US Propylene Industry, Installed Plant Capacity by Key Feedstock, Table 71: The US, Propylene Industry, Installed Plant Capacity by Naphtha, Table 72: The US, Propylene Industry, Installed Plant Capacity by Naphtha, 2012 (Contd.) 73 Table 73: The US, Propylene Industry, Installed Plant Capacity by Natural Gas, Table 74: The US, Propylene Industry, Installed Plant Capacity by Natural Gas, 2012 (Contd.) 74 GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 6

7 Table 75: The US Propylene Industry, Installed Plant Capacity by Production Process, Table 76: The US, Propylene Industry, Installed Plant Capacity by Fluid Catalytic Cracking, Table 77: The US, Propylene Industry, Installed Plant Capacity by Fluid Catalytic Cracking, 2012 (Contd.) 76 Table 78: The US, Propylene Industry, Installed Plant Capacity by Steam Cracking, Table 79: The US, Propylene Industry, Installed Plant Capacity by Olefin Metathesis, Table 80: The US, Propylene Industry, Installed Plant Capacity by Deep Catalytic Cracking, Table 81: The US, Propylene Industry, Installed Plant Capacity by Propane Dehydrogenation, Table 82: The US Propylene Industry, Installed Plant Capacity by Technology, Table 83: The US, Propylene Industry, Installed Plant Capacity by CB&I Lummus (OCT) Propylene Technology, Table 84: The US, Propylene Industry, Installed Plant Capacity by Linde AG Propylene Technology, Table 85: The US, Propylene Industry, Installed Plant Capacity by KBR Superflex Propylene Technology, Table 86: The US, Propylene Industry, Installed Plant Capacity by Stone & Webster Propylene Technology, Table 87: The US, Propylene Industry, Installed Plant Capacity by CB&I Lummus (Catofin) Propylene Technology, Table 88: The US, Propylene Industry, Installed Plant Capacity by Company, %, Table 89: The US, Propylene Industry, Planned Projects, Table 90: The US, Propylene Industry, Demand Value, $bn, Table 91: The US, Propylene Industry, Demand and Production, MMTPA, Table 92: The US, Propylene Industry, Demand by End Use Sector, %, Table 93: The US, Propylene Industry, Price Forecasts, $/Tonne, Table 94: The US, Propylene Industry, Imports and Exports, MMTPA, Table 95: The US, Propylene Industry, Net Exports, MMTPA, Table 96: The US, Propylene Industry, Imports as Percentage of Demand, %, Table 97: Canada, Total Propylene Plant Capacity, MMTPA, Table 98: Canada, Major Propylene Plants Capacity, MMTPA, Table 99: Canada, Active Propylene Plants by State, %, Table 100: Canada, Major Active Propylene Plant Details, MMTPA, Table 101: Canada, Top Propylene Plants Capacity, %, Table 102: Canada, Top Propylene Plant Details, Table 103: Canada, Propylene Industry, Planned Projects, Table 104: Canada, Propylene Industry, Demand Value, $bn, Table 105: Canada, Propylene Industry, Demand and Production, MMTPA, Table 106: Canada, Propylene Industry, Demand by End Use Sector, %, Table 107: Canada, Propylene Industry, Price Forecasts, $/Tonne, Table 108: Canada, Propylene Industry, Imports and Exports, MMTPA, Table 109: Canada, Propylene Industry, Net Exports, MMTPA, Table 110: Canada, Propylene Industry, Imports as Percentage of Demand, %, Table 111: LyondellBasell Industries N.V., Key Facts 114 Table 112: LyondellBasell Industries N.V., Propylene Capacity Split, North America and Rest of the World,%, Table 113: North America, LyondellBasell Industries N.V., Propylene Capacity Share, %, Table 114: North America, LyondellBasell Industries N.V., Propylene Plant Capacity, MMTPA, Table 115: North America, LyondellBasell Industries N.V., Propylene Plant Details, Table 116: LyondellBasell Industries N.V., SWOT Analysis 120 Table 117: Exxon Mobil Corporation, Key Facts 125 GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 7

8 Table 118: Exxon Mobil Corporation, Propylene Capacity Split, North America and Rest of the World,%, Table 119: North America, Exxon Mobil Corporation, Propylene Capacity Share, %, Table 120: North America, Exxon Mobil Corporation, Propylene Plant Capacity, MMTPA, Table 121: North America, Exxon Mobil Corporation, Propylene Plant Details, Table 122: Exxon Mobil Corporation, SWOT Analysis 132 Table 123: Royal Dutch Shell plc, Propylene Capacity Split, North America and Rest of the World,%, Table 124: North America, Royal Dutch Shell plc, Propylene Capacity Share, %, Table 125: North America, Royal Dutch Shell plc, Propylene Plant Capacity, MMTPA, Table 126: North America, Royal Dutch Shell plc, Propylene Plant Details, Table 127: Royal Dutch Shell plc, SWOT Analysis List of Figures Figure 1: North America, Total Propylene Plant Capacity, MMTPA, Figure 2: Propylene Industry, Total Plant Capacity by Region, MMTPA, Figure 3: North America, Active Propylene Capacity Share by Country, %, Figure 4: North America, Active Propylene Plants Share by Country, %, Figure 5: North America, Top Propylene Plants Capacity, %, Figure 6: North America Propylene Industry, Installed Plant Capacity by Key Feedstock, Figure 7: North America Propylene Industry, Installed Plant Capacity by Production Process, Figure 8: North America Propylene Industry, Installed Plant Capacity by Technology, Figure 9: North America, Propylene Industry, Installed Plant Capacity by Company, %, Figure 10: North America, Propylene Industry, Demand Value, $bn, Figure 11: Propylene Industry, Demand Value Growth by Region, $bn, Figure 12: North America, Propylene Industry, Demand and Production, MMTPA, Figure 13: Propylene Industry, Demand by Region, MMTPA, Figure 14: Propylene Industry, Production by Region, MMTPA, Figure 15: North America, Propylene Industry, Production by Country, %, Figure 16: North America, Propylene Industry, Demand by Country, %, Figure 17: North America, Propylene Industry, Demand by End Use Sector, %, Figure 18: Propylene Industry, End Use by Regions, MMTPA, Figure 19: North America, Propylene Industry, Price Forecasts, $/Tonne, Figure 20: Propylene Industry, Average Price by Region, $/Tonne, Figure 21: The US, Total Propylene Plant Capacity, MMTPA, Figure 22: The US, Active Propylene Plants by State, %, Figure 23: The US, Top Propylene Plants Capacity, %, Figure 24: The US Propylene Industry, Installed Plant Capacity by Key Feedstock, Figure 25: The US Propylene Industry, Installed Plant Capacity by Production Process, Figure 26: The US Propylene Industry, Installed Plant Capacity by Technology, Figure 27: The US, Propylene Industry, Installed Plant Capacity by Company, %, Figure 28: The US, Propylene Industry, Demand Value, $bn, Figure 29: The US, Propylene Industry, Demand and Production, MMTPA, Figure 30: The US, Propylene Industry, Demand by End Use Sector, %, Figure 31: The US, Propylene Industry, Price Forecasts, $/Tonne, GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 8

9 Figure 32: The US, Propylene Industry, Imports and Exports, MMTPA, Figure 33: The US, Propylene Industry, Net Exports, MMTPA, Figure 34: The US, Propylene Industry, Imports as Percentage of Demand, %, Figure 35: Canada, Total Propylene Plant Capacity, MMTPA, Figure 36: Canada, Active Propylene Plants by State, %, Figure 37: Canada, Top Propylene Plants Capacity, %, Figure 38: Canada, Propylene Industry, Demand Value, $bn, Figure 39: Canada, Propylene Industry, Demand and Production, MMTPA, Figure 40: Canada, Propylene Industry, Demand by End Use Sector, %, Figure 41: Canada, Propylene Industry, Price Forecasts, $/Tonne, Figure 42: Canada, Propylene Industry, Imports and Exports, MMTPA, Figure 43: Canada, Propylene Industry, Net Exports, MMTPA, Figure 44: Canada, Propylene Industry, Imports as Percentage of Demand, %, Figure 45: LyondellBasell Industries N.V., Propylene Capacity Split, North America and Rest of the World,%, Figure 46: North America, LyondellBasell Industries N.V., Propylene Capacity Share, %, Figure 47: Exxon Mobil Corporation, Propylene Capacity Split, North America and Rest of the World,%, Figure 48: North America, Exxon Mobil Corporation, Propylene Capacity Share, %, Figure 49: Royal Dutch Shell plc, Propylene Capacity Split, North America and Rest of the World,%, Figure 50: North America, Royal Dutch Shell plc, Propylene Capacity Share, %, GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 9

10 2 North America Propylene Industry, Supply Scenario, North America Propylene Industry, Total Plant Capacity, Figure 1: North America, Total Propylene Plant Capacity, MMTPA, Source: GlobalData, Petrochemicals etrack GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 10

11 Table 1: North America, Total Propylene Plant Capacity, MMTPA, Year Capacity Source: GlobalData, Petrochemicals etrack GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 11

12 Figure 2: Propylene Industry, Total Plant Capacity by Region, MMTPA, Source: GlobalData, Petrochemicals etrack Table 2: Propylene Industry, Total Plant Capacity by Region, MMTPA, Region Source: GlobalData, Petrochemicals etrack GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 12

13 Table 3: North America, Major Propylene Plants Capacity, MMTPA, Plant Name Source: GlobalData, Petrochemicals etrack Table 4: North America, Major Propylene Plants Capacity, MMTPA, (Contd.) Plant Name Source: GlobalData, Petrochemicals etrack GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 13

14 Appendix 8 Appendix 8.1 Definitions Installed Plant Capacity The maximum rated output of a plant under specific conditions designated by the manufacturer. The installed capacity is usually indicated in units of tonnes on a nameplate physically attached to the plant Key Feedstock Process The key feedstock in the petrochemical industry refers to the primary raw materials that serve as a building block for the entire petrochemicals industry. Naphtha, natural gas, Liquefied Petroleum Gas (LPG), ethanol and coal are the key feedstocks being used in the petrochemical industry. A process is a combination of unit operations used in the manufacturing of petrochemicals to change the composition of chemicals Technology Technology is referred to as a technical process used in the petrochemical industry, which is developed by a specific business entity. 8.2 Abbreviations MMTPA - Million Metric Tonnes per Annum CAGR - Compounded Annual Growth Rate 8.3 GlobalData s Methodology Coverage GlobalData s dedicated research and analysis teams consists of experienced professionals with marketing, market research and consulting backgrounds in the petrochemical industry and advanced statistical expertise. GlobalData adheres to the codes of practice of the Market Research Society ( and the Society of Competitive Intelligence Professionals ( All GlobalData databases are continuously updated and revised. The objective of updating GlobalData s coverage is to ensure that it represents the most up to date vision of the industry possible. Changes to the industry taxonomy are built on the basis of extensive research of company, association and competitor sources. Company coverage is based on three key factors: market capitalization, revenues and media attention/innovation/market potential. GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 154

15 Appendix An exhaustive search of 56 member exchanges is conducted and companies are prioritized on the basis of their market capitalization. The estimated revenues of all major companies, including private and governmental, are gathered and used to prioritize coverage. Companies which are making the news, or which are of particular interest due to their innovative approach, are prioritized. GlobalData aims to cover all major news events and deals in the petrochemical industry, updated on a daily basis. The coverage is further streamlined and strengthened with additional inputs from GlobalData s expert panel (see below) Secondary Research The research process begins with exhaustive secondary research on internal and external sources being carried out to source qualitative and quantitative information relating to each market. The secondary research sources that are typically referred to include, but are not limited to: Company websites, annual reports, financial reports, broker reports, investor presentations and MexicoSecurities and Exchanges Commission (SEC) filings. Industry trade journals and other literature. Internal and external proprietary databases. National government documents, statistical databases and market reports. News articles, press releases and web-casts specific to the companies operating in the market Primary Research GlobalData conducts hundreds of primary interviews a year with industry participants and commentators in order to validate its data and analysis. A typical research interview fulfills the following functions: It provides first-hand information on market size, market trends, growth trends, competitive landscape, and future outlooks for markets and sectors. It helps in validating and strengthening secondary research findings. It further develops the analysis team s expertise and market understanding. Primary research involves interactions, telephone interviews and face-to-face interviews for each market, category, segment and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to: Industry participants: CEOs, VPs, business development managers, market intelligence managers and national sales managers, Outside experts: investment bankers, valuation experts, research analysts and key opinion leaders specializing in petrochemicals markets. GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 155

16 Appendix Expert Panel Validation GlobalData uses a panel of experts to cross-verify research and forecast methodologies and drive its analytical content. The GlobalData expert panel comprises marketing managers, product specialists, international sales managers from petrochemical companies; academics and geologists from research universities, consultants from venture capital funds and distributors/suppliers of petrochemicals goods and services. Details of the makeup of the expert panel can be viewed through the GlobalData website, and are available to clients on request. 8.4 Disclaimer All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publisher, GlobalData. GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 156

BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020

BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020 BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook Reference Code: GDMECR0130PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...

More information

SAMPLE. Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to Reference Code: GDME0166BDB

SAMPLE. Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to Reference Code: GDME0166BDB Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0166BDB Publication Date: January 2013 GlobalData. This report is a licensed product

More information

Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020

Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Reference Code: GDMECR0195DB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List

More information

SAMPLE. Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

SAMPLE. Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0165BDB Publication Date: January 2013 GlobalData. This report

More information

EU5 Bariatric Surgery Procedures Outlook to 2020

EU5 Bariatric Surgery Procedures Outlook to 2020 EU5 Bariatric Surgery Procedures Outlook to 2020 Reference Code: GDMECR0089PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...

More information

Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020

Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Reference Code: GDMECR0107PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3

More information

Mexico Ostomy Drainage Bags Market Outlook to 2020

Mexico Ostomy Drainage Bags Market Outlook to 2020 Mexico Ostomy Drainage Bags Market Outlook to 2020 Reference Code: GDMECC0990DB Publication Date: October 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List of Figures...

More information

China Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020

China Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020 China Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020 Reference Code: GDMECC0079DB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2

More information

Asia-Pacific Electrophysiology Market Outlook to 2020

Asia-Pacific Electrophysiology Market Outlook to 2020 Asia-Pacific Electrophysiology Market Outlook to 2020 Reference Code: GDMECR0114DB Publication Date: May 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 5 1.2 List of Figures...

More information

SAMPLE. South and Central America Drug Delivery Devices Market Outlook to Metered Dose Inhaler Devices, Infusion Systems, Central

SAMPLE. South and Central America Drug Delivery Devices Market Outlook to Metered Dose Inhaler Devices, Infusion Systems, Central South and Central America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others Reference Code: GDME0222RDB Publication Date:

More information

Oncology Therapeutics Market in India to 2018

Oncology Therapeutics Market in India to 2018 Oncology Therapeutics Market in India to 2018 Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players GBI Research Report Guidance GBI Research

More information

SAMPLE. South Korea Orthopedic Procedures Outlook to Reference Code: GDMEMC0008PDB. Publication Date: March 2014

SAMPLE. South Korea Orthopedic Procedures Outlook to Reference Code: GDMEMC0008PDB. Publication Date: March 2014 South Korea Orthopedic Procedures Outlook to 2020 Reference Code: GDMEMC0008PDB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List of Figures...

More information

Ostomy Drainage Bags Market to Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth Potential

Ostomy Drainage Bags Market to Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth Potential Ostomy Drainage Bags Market to 2019 Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth Potential GBI Research Report Guidance GBI Research Report Guidance

More information

SAMPLE. Asia-Pacific Drug Delivery Devices Market Outlook to Metered Dose Inhaler Devices, Infusion Systems, Central Venous

SAMPLE. Asia-Pacific Drug Delivery Devices Market Outlook to Metered Dose Inhaler Devices, Infusion Systems, Central Venous Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others Reference Code: GDME0220RDB Publication Date: January 2013

More information

France Interventional Cardiology Market Outlook to 2020

France Interventional Cardiology Market Outlook to 2020 France Interventional Cardiology Market Outlook to 2020 Reference Code: GDMECC0358DB Publication Date: May 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List of Figures...

More information

SAMPLE. Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to Reference Code: GDHC0004RCCDVR Publication Date: March 2012

SAMPLE. Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to Reference Code: GDHC0004RCCDVR Publication Date: March 2012 Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to Reference Code: GDHC0004RCCDVR Publication Date: March 2012 The Renal Cell Carcinoma (RCC) Disease Therapeutics Market GlobalData s analysis suggests

More information

SAMPLE. Cerebral Palsy Global Clinical Trials Review, H1, 2014

SAMPLE. Cerebral Palsy Global Clinical Trials Review, H1, 2014 Cerebral Palsy Global Clinical Trials Review, H1, 2014 Reference Code: GDHC2156CTIDB Publication Date: MAY 2014 Page 1 Table of Contents Table of Contents... 2 List of Tables... 4 List of Figures... 5

More information

North America Propylene Supply Study

North America Propylene Supply Study North America Propylene Supply Study Table of Contents Introduction 3 Lead Author, Chuck Carr 4 Supporting Authors 5 IHS Chemical Special Reports 5 Available Now 5 Upcoming 5 Contact List 6 Explanatory

More information

Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019

Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019 Reference Code: GDHC504PRT Publication Date: January 2013 Cytomegalovirus Infections: Key Metrics in Seven Major Pharmaceutical Markets 2012 Epidemiology* Prevalent population (CMV prevalent cases in general

More information

The Cigarette Market in Saudi Arabia

The Cigarette Market in Saudi Arabia The Cigarette Market in Saudi Arabia Product Code: CG0173MR Published Date: June 2015 Report Price: US$ 975 (Single Copy) Synopsis Cigarettes in Saudi Arabia report is a qualitative report providing extensive

More information

Russia Cardiac Assist Devices Market Outlook to 2021

Russia Cardiac Assist Devices Market Outlook to 2021 Russia Cardiac Assist Devices Market Outlook to 2021 Russia Cardiac Assist Devices Market Outlook to 2021 BioPortfolio has been marketing business and market research reports from selected publishers for

More information

The Cigarette Market in Belarus

The Cigarette Market in Belarus The Cigarette Market in Belarus Product Code: CG0155MR Published Date: June 2015 Report Price: US$ 975 (Single Copy) Synopsis Cigarettes in Belarus report is a qualitative report providing extensive and

More information

The Cigarette Market in Greece

The Cigarette Market in Greece The Cigarette Market in Greece Product Code: CG0145MR Published Date: April 2015 Report Price: US$ 975 (Single Copy) Synopsis Cigarettes in Greece report is a qualitative report providing extensive and

More information

REFERENCE CODE GDHC1032FPR PUBLICAT ION DATE M ARCH 2014 PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES - CURRENT AND FUTURE PLAYERS

REFERENCE CODE GDHC1032FPR PUBLICAT ION DATE M ARCH 2014 PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES - CURRENT AND FUTURE PLAYERS REFERENCE CODE GDHC1032FPR PUBLICAT ION DATE M ARCH 2014 PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES - Executive Summary Human PapillomaVirus (HPV) Vaccine Sales Expected to Grow Modestly During the Forecast

More information

REFERENCE CODE GDHC386DFR PUBLICAT ION DATE M ARCH 2014 GARDASIL (PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC386DFR PUBLICAT ION DATE M ARCH 2014 GARDASIL (PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC386DFR PUBLICAT ION DATE M ARCH 2014 GARDASIL (PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022 Executive Summary Gardasil: Key Metrics in Nine Major

More information

Kaletra (HIV) Forecast and Market Analysis to GDHC1051DFR/ Published January 2013

Kaletra (HIV) Forecast and Market Analysis to GDHC1051DFR/ Published January 2013 Kaletra (HIV) Forecast and Market Analysis to 2022 GDHC1051DFR/ Published January 2013 Executive Summary Kaletra Key Metrics in the Nine Major Pharmaceutical Markets 2012 Market Sales US - Kaletra 5EU

More information

Parenteral Nutrition Market to 2018

Parenteral Nutrition Market to 2018 Parenteral Nutrition Market to 2018 Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth GBI Research Report

More information

REFERENCE CODE GDHC294DFR PUBLICATION DATE NOVEMBER 2013 PROTOPIC (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC294DFR PUBLICATION DATE NOVEMBER 2013 PROTOPIC (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC294DFR PUBLICATION DATE NOVEMBER 2013 PROTOPIC (ATOPIC DERMATITIS) Executive Summary The below mentioned table presents key metrics for Protopic in the nine major pharmaceutical markets

More information

The Cigarette Market in Netherlands

The Cigarette Market in Netherlands The Cigarette Market in Netherlands Product Code: CG0148MR Published Date: April 2015 Report Price: US$ 975 (Single Copy) Synopsis Cigarettes in Austria report is a qualitative report providing extensive

More information

Tobacco Insights May

Tobacco Insights May Tobacco Insights 2015 - May Product Code: TI0017MR Published Date: June 2015 Report Price: US$ 150 (Single Copy) Synopsis Tobacco Insights 2015 - May report is a qualitative report providing extensive

More information

REFERENCE CODE GDHC295DFR PUBLICATION DATE NOVEMBER 2013 ELIDEL (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC295DFR PUBLICATION DATE NOVEMBER 2013 ELIDEL (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC295DFR PUBLICATION DATE NOVEMBER 2013 ELIDEL (ATOPIC DERMATITIS) Executive Summary The below mentioned table presents key metrics for Elidel in the major pharmaceutical markets: the

More information

REFERENCE CODE GDHC1087DFR PUBLICATION DATE JUNE 2013

REFERENCE CODE GDHC1087DFR PUBLICATION DATE JUNE 2013 REFERENCE CODE GDHC1087DFR PUBLICATION DATE JUNE 2013 Executive Summary Diovan (valsartan): Key Metrics in the Seven Major Pharmaceutical Markets* 2012 Market Sales US - Diovan 5EU - Diovan Japan - Diovan

More information

GLOBAL NEUROSTIMULATION MARKET

GLOBAL NEUROSTIMULATION MARKET GLOBAL NEUROSTIMULATION MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d

More information

Rituxan (Rheumatoid Arthritis)

Rituxan (Rheumatoid Arthritis) Rituxan (Rheumatoid Arthritis) Forecast and Market Analysis GDHC1008DFR / Published November 2012 Executive Summary Rituxan: Key Metrics in Rheumatoid Arthritis Markets 2012 Rituxan Sales Total 7 MM $835m

More information

Orencia (Rheumatoid Arthritis)

Orencia (Rheumatoid Arthritis) Orencia (Rheumatoid Arthritis) Forecast and Market Analysis GDHC1006DFR / Published November 2012 Executive Summary Orencia: Key Metrics in Rheumatoid Arthritis Markets 2012 Orencia Sales Total 7 MM $831m

More information

REFERENCE CODE GDHC1062CFR PUBLICATION DATE JUNE 2013 CHRONIC HEART FAILURE - JAPAN DRUG FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC1062CFR PUBLICATION DATE JUNE 2013 CHRONIC HEART FAILURE - JAPAN DRUG FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC1062CFR PUBLICATION DATE JUNE 2013 CHRONIC HEART FAILURE - JAPAN DRUG Executive Summary Sales for Chronic Heart Failure in the Japan The Japan Chronic heart failure (CHF) therapeutics

More information

REFERENCE CODE GDHC296DFR PUBLICATION DATE NOVEMBER 2013 DUPILUMAB (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC296DFR PUBLICATION DATE NOVEMBER 2013 DUPILUMAB (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC296DFR PUBLICATION DATE NOVEMBER 2013 DUPILUMAB (ATOPIC DERMATITIS) Executive Summary The below mentioned table presents key metrics for Dupilumab in the nine major pharmaceutical markets

More information

Nephrology and Urology Devices Market to Usage of. Incontinence devices by the Elderly Population to Drive Market

Nephrology and Urology Devices Market to Usage of. Incontinence devices by the Elderly Population to Drive Market Incontinence devices by the Elderly Population to Drive Market Reference Code: GBIME0030MR Publication Date: April 2011 The global market for nephrology and urology devices is forecast to exceed $XX billion

More information

REFERENCE CODE GDHC282DFR PUBLICATION DATE OCTOBER 2013 BELVIQ (OBESITY) - FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC282DFR PUBLICATION DATE OCTOBER 2013 BELVIQ (OBESITY) - FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC282DFR PUBLICATION DATE OCTOBER 2013 BELVIQ (OBESITY) - Executive Summary Below table provides a summary of Belviq for obesity in the nine major pharmaceutical markets during the forecast

More information

Dry Eye Syndrome - Current and Future Players. GDHC1016FPR / Published May 2013

Dry Eye Syndrome - Current and Future Players. GDHC1016FPR / Published May 2013 Dry Eye Syndrome - Current and Future Players GDHC1016FPR / Published May 2013 Executive Summary Significant growth is expected in the DES market from 2012-2022. GlobalData estimates 2012 DES therapeutic

More information

Bariatric Surgery Devices - North America Analysis and Market Forecasts

Bariatric Surgery Devices - North America Analysis and Market Forecasts Bariatric Surgery Devices - North America Analysis and Market Forecasts Bariatric Surgery Devices - North America Analysis and Market Forecasts BioPortfolio has been marketing business and market research

More information

REFERENCE CODE GDHC361DFR PUBLICAT ION DATE FEBRUARY 2014 INVEGA (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC361DFR PUBLICAT ION DATE FEBRUARY 2014 INVEGA (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC361DFR PUBLICAT ION DATE FEBRUARY 2014 INVEGA (SCHIZOPHRENIA) Executive Summary Invega : Key Metrics in the Seven Major Pharmaceutical Markets, 2012 2022 2012 Market Sales US 5EU Japan

More information

REFERENCE CODE GDHC1155DFR PUBLICAT ION DATE SEPTEMBER 2013 NIMENRIX (MENINGOCOCCAL VACCINES) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC1155DFR PUBLICAT ION DATE SEPTEMBER 2013 NIMENRIX (MENINGOCOCCAL VACCINES) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC1155DFR PUBLICAT ION DATE SEPTEMBER 2013 NIMENRIX (MENINGOCOCCAL VACCINES) Executive Summary Nimenrix: Key Metrics in the Nine Major Pharmaceutical Markets 2012 Market Sales US 5EU Japan

More information

REFERENCE CODE GDHC1161DFR PUBLICAT ION DATE SEPTEMBER 2013 MENOMUNE (MENINGOCOCCAL VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC1161DFR PUBLICAT ION DATE SEPTEMBER 2013 MENOMUNE (MENINGOCOCCAL VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC1161DFR PUBLICAT ION DATE SEPTEMBER 2013 MENOMUNE (MENINGOCOCCAL VACCINES) - Executive Summary Menomune: Key Metrics in the Nine Major Pharmaceutical Markets 2012 Market Sales US 5EU

More information

REFERENCE CODE GDHC357DFR PUBLICAT ION DATE FEBRUARY 2014 CLOZARIL (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC357DFR PUBLICAT ION DATE FEBRUARY 2014 CLOZARIL (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC357DFR PUBLICAT ION DATE FEBRUARY 2014 CLOZARIL (SCHIZOPHRENIA) Executive Summary Clozaril: Key Metrics in the Seven Major Pharmaceutical Markets, 2012 2022 2012 Market Sales US 5EU

More information

LUPUZOR (SYSTEMIC LUPUS ERYTHEMATOSUS AND LUPUS NEPHRITIS) - FORECAST AND MARKET ANALYSIS TO 2022

LUPUZOR (SYSTEMIC LUPUS ERYTHEMATOSUS AND LUPUS NEPHRITIS) - FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC279DFR PUBLICATION DATE OCTOBER 2013 LUPUZOR (SYSTEMIC LUPUS ERYTHEMATOSUS AND Executive Summary Table below presents the key metrics of Lupuzor for Systemic Lupus Erythematosus (SLE)

More information

About The Report. imarc. Key Questions Answered in this Report:

About The Report. imarc. Key Questions Answered in this Report: About IMARC For more than 5 years, the International Market Analysis Research and Consulting Group has been a leading advisor on management strategy and market research worldwide. We partner with clients

More information

North America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021

North America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 North America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 North America Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 BioPortfolio has been marketing business and market research

More information

REFERENCE CODE GDHC013POA PUBLICAT ION DATE DECEM BER 2013

REFERENCE CODE GDHC013POA PUBLICAT ION DATE DECEM BER 2013 REFERENCE CODE GDHC013POA PUBLICAT ION DATE DECEM BER 2013 ACUTE ISCHEMIC STROKE - Executive Summary Acute Ischemic Stroke: Key Metrics in Six Major Pharmaceutical Markets 2012 Epidemiology Prevalent Cases

More information

Segment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage

Segment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (35 years): Forecast to 2022 By Type - Pap Test, HPV Test,

More information

Keppra (Epilepsy) Forecast and Market Analysis to Reference Code: GDHC1061DFR Publication Date: February 2013

Keppra (Epilepsy) Forecast and Market Analysis to Reference Code: GDHC1061DFR Publication Date: February 2013 Keppra (Epilepsy) Forecast and Market Analysis to 2022 Reference Code: GDHC1061DFR Publication Date: February 2013 Executive Summary Keppra (levetiracetam) Key Metrics in the Nine Major Pharmaceutical

More information

REFERENCE CODE GDHC200DFR PUBLICAT ION DATE JUNE 2013 AVASTIN (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC200DFR PUBLICAT ION DATE JUNE 2013 AVASTIN (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC200DFR PUBLICAT ION DATE JUNE 2013 AVASTIN (NON-SMALL CELL LUNG CANCER) AVASTIN (NON-SMALL CELL LUNG CANCER) - Executive Summary Avastin (bevacizumab): Key Metrics in NSCLC Markets 2012

More information

REFERENCE CODE GDHC198DFR PUBLICAT ION DATE JUNE 2013 TARCEVA (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC198DFR PUBLICAT ION DATE JUNE 2013 TARCEVA (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC198DFR PUBLICAT ION DATE JUNE 2013 TARCEVA (NON-SMALL CELL LUNG CANCER) Executive Summary Tarceva (erlotinib): Key Metrics in NSCLC Markets 2012 Tarceva Sales US 5EU Japan China India

More information

REFERENCE CODE GDHC199DFR PUBLICAT ION DATE JUNE 2013 XALKORI (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC199DFR PUBLICAT ION DATE JUNE 2013 XALKORI (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC199DFR PUBLICAT ION DATE JUNE 2013 XALKORI (NON-SMALL CELL LUNG CANCER) Executive Summary Xalkori (crizotinib): Key Metrics in NSCLC Markets 2012 Xalkori Sales US 5EU Japan China India

More information

Global Standard Radiography Film X-Ray Film Printer Market Research Report 2016

Global Standard Radiography Film X-Ray Film Printer Market Research Report 2016 Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Standard Radiography Film X-Ray Film Printer Market Research Report 2016 Global Standard Radiography Film

More information

Actemra (Rheumatoid Arthritis)

Actemra (Rheumatoid Arthritis) Actemra (Rheumatoid Arthritis) Forecast and Market Analysis GDHC1007DFR / Published November 2012 Executive Summary Actemra: Key Metrics in Rheumatoid Arthritis Markets 2012 Actemra Sales Total 7 MM $355m

More information

REFERENCE CODE GDHC356DFR PUBLICAT ION DATE FEBRUARY 2014 SAPHRIS (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC356DFR PUBLICAT ION DATE FEBRUARY 2014 SAPHRIS (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC356DFR PUBLICAT ION DATE FEBRUARY 2014 SAPHRIS (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSISTO 2022 Executive Summary Saphris: Key Metrics in the Seven Major Pharmaceutical Markets, 2012

More information

REFERENCE CODE GDHC224CFR PUBLICAT ION DATE FEBRUARY 2014 SCHIZOPHRENIA US DRUG FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC224CFR PUBLICAT ION DATE FEBRUARY 2014 SCHIZOPHRENIA US DRUG FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC224CFR PUBLICAT ION DATE FEBRUARY 2014 SCHIZOPHRENIA Executive Summary Schizophrenia Sales in the US, 2012 The combined sales of medications carrying an indication in schizophrenia in

More information

Dry Eye Syndrome. US Drug Forecast and Market Analysis to GDHC1115CFR / Published May 2013

Dry Eye Syndrome. US Drug Forecast and Market Analysis to GDHC1115CFR / Published May 2013 Dry Eye Syndrome US Drug Forecast and Market Analysis to 2022 GDHC1115CFR / Published May 2013 Executive Summary Sales for Dry Eye Syndrome in the US The Dry Eye Syndrome (DES) market in the US will grow

More information

Global Chymosin Market Research Report 2016

Global Chymosin Market Research Report 2016 Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Chymosin Market Research Report 2016 Global Chymosin Market Research Report 2016 Publication ID: QYR101602046

More information

PegIntron (Hepatitis C Virus) Forecast and Market Analysis to GDHC1143DFR / Published May 2013

PegIntron (Hepatitis C Virus) Forecast and Market Analysis to GDHC1143DFR / Published May 2013 PegIntron (Hepatitis C Virus) Forecast and Market Analysis to 2022 GDHC1143DFR / Published May 2013 Executive Summary PegIntron (peginterferon alfa-2b) Key Metrics in the Major Pharmaceutical Markets 2012

More information

REFERENCE CODE GDHC366DFR PUBLICAT ION DATE FEBRUARY 2014 CARIPRAZINE (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC366DFR PUBLICAT ION DATE FEBRUARY 2014 CARIPRAZINE (SCHIZOPHRENIA) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC366DFR PUBLICAT ION DATE FEBRUARY 2014 CARIPRAZINE (SCHIZOPHRENIA) Executive Summary Table below provides a summary of the key metrics for Cariprazine in the seven major pharmaceutical

More information

Brachytherapy Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018

Brachytherapy Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018 Brachytherapy Devices - Global Opportunity Assessment, Competitive Reference Code: GDME0161MAR Publication Date: August 2012 The Global Brachytherapy Devices Market is Expected to Grow During the Forecast

More information

Chronic Myeloid Leukemia (CML)

Chronic Myeloid Leukemia (CML) Chronic Myeloid Leukemia (CML) Japan Drug Forecast and Market Analysis to 2022 GDHC1088CFR / Published April 2013 Executive Summary Sales for CML in Japan The Japan CML therapeutics market in the 7MM is

More information

Global Magnetic Resonance Imaging (MRI) Systems Market Research Report 2016

Global Magnetic Resonance Imaging (MRI) Systems Market Research Report 2016 Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Magnetic Resonance Imaging (MRI) Systems Market Research Report 2016 Global Magnetic Resonance Imaging (MRI)

More information

Synribo (Chronic Myeloid Leukemia)

Synribo (Chronic Myeloid Leukemia) Synribo (Chronic Myeloid Leukemia) Forecast and Market Analysis to 2022 GDHC1141DFR / Published May 2013 Executive Summary Synribo (omacetaxine mepesuccinate): Key Metrics in CML Markets 2012 Synribo Sales

More information

Diquas (Dry Eye Syndrome)

Diquas (Dry Eye Syndrome) Diquas (Dry Eye Syndrome) Forecast and Market Analysis to 2022 GDHC187DFR / Published July 2013 Executive Summary Below table provides a summary of the key metrics for Diquas in the global Dry Eye Syndrome

More information

Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2016

Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2016 Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2016 Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2016 BioPortfolio has been marketing business

More information

REFERENCE CODE GDHC423DFR PUBLICAT ION DATE M AY 2014 ABILIFY (MAJOR DEPRESSIVE DISORDER) - FORECAST AND MARKET ANALYSIS TO 2023

REFERENCE CODE GDHC423DFR PUBLICAT ION DATE M AY 2014 ABILIFY (MAJOR DEPRESSIVE DISORDER) - FORECAST AND MARKET ANALYSIS TO 2023 REFERENCE CODE GDHC423DFR PUBLICAT ION DATE M AY 2014 ABILIFY (MAJOR DEPRESSIVE DISORDER) - Executive Summary Table below presents the key metrics for Abilify in the seven major pharmaceutical markets

More information

DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC)

DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC) DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC) R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p

More information

REFERENCE CODE GDHC109PIDR PUBLICAT ION DATE MAY 2015 FIBROMYALGIA GLOBAL DRUG FORECAST AND MARKET ANALYSIS TO 2023

REFERENCE CODE GDHC109PIDR PUBLICAT ION DATE MAY 2015 FIBROMYALGIA GLOBAL DRUG FORECAST AND MARKET ANALYSIS TO 2023 REFERENCE CODE GDHC109PIDR PUBLICAT ION DATE MAY 2015 FIBROMYALGIA GLOBAL DRUG FORECAST AND MARKET ANALYSIS TO 2023 Executive Summary Fibromyalgia: Key Metrics in Seven Major Pharmaceutical Markets, 2013

More information

Reference Code: GDME1163IDB. Czech Republic Dental Devices Market Outlook to CAD/CAM Dental Systems, Dental Chairs and Equipment, Dental

Reference Code: GDME1163IDB. Czech Republic Dental Devices Market Outlook to CAD/CAM Dental Systems, Dental Chairs and Equipment, Dental Czech Republic Dental Devices Market Outlook to 2018 - CAD/CAM Dental Systems, Dental Chairs and Equipment, Dental Implants, Dental Biomaterials, Crowns and Bridges and Others Reference Code: GDME1163IDB

More information

REFERENCE CODE GDHC398DFR PUBLICAT ION DATE M ARCH 2014 SAFINAMIDE (PARKINSON S DISEASE) - FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC398DFR PUBLICAT ION DATE M ARCH 2014 SAFINAMIDE (PARKINSON S DISEASE) - FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC398DFR PUBLICAT ION DATE M ARCH 2014 SAFINAMIDE (PARKINSON S DISEASE) - Executive Summary The table below summarizes the key metrics for Safinamide in the 8MM Parkinson s disease (PD)

More information

IHS CHEMICAL Upgradation of Pygas C 5 Cut to Produce Isoprene and Other Products

IHS CHEMICAL Upgradation of Pygas C 5 Cut to Produce Isoprene and Other Products ` IHS CHEMICAL Upgradation of Pygas C 5 Cut to Produce Isoprene and Other Products April 2016 ihs.com Upgradation of Pygas C 5 Cut to Produce Isoprene and Other Products Rajesh Kumar Verma Principal Analyst

More information

Global Cosmetic Dentistry Market Research Report 2018

Global Cosmetic Dentistry Market Research Report 2018 Report Information More information from: https://www.wiseguyreports.com/reports/3029111-global-cosmetic-dentistry-market-research-report- 2018 Global Cosmetic Dentistry Market Research Report 2018 Report

More information

REFERENCE CODE GDHC420DFR PUBLICAT ION DATE M AY 2014 FETZIMA (MAJOR DEPRESSIVE DISORDER) - FORECAST AND MARKET ANALYSIS TO 2023

REFERENCE CODE GDHC420DFR PUBLICAT ION DATE M AY 2014 FETZIMA (MAJOR DEPRESSIVE DISORDER) - FORECAST AND MARKET ANALYSIS TO 2023 REFERENCE CODE GDHC420DFR PUBLICAT ION DATE M AY 2014 FETZIMA (MAJOR DEPRESSIVE DISORDER) - Executive Summary Table below presents the key metrics for Fetzima in the seven major pharmaceutical markets

More information

More information at

More information at Report Information More information at https://www.htfmarketreport.com/reports/1288313 Global Homeopathic Products Market Professional Survey Report 2018 Report Code: HTF1288313 Pages: 111 Price: 1-User

More information

Lamictal (Epilepsy) Forecast and Market Analysis to Reference Code: GDHC1062DFR Publication Date: February 2013

Lamictal (Epilepsy) Forecast and Market Analysis to Reference Code: GDHC1062DFR Publication Date: February 2013 Lamictal (Epilepsy) Forecast and Market Analysis to 2022 Reference Code: GDHC1062DFR Publication Date: February 2013 Executive Summary Lamictal (lamotrigine) Key Metrics in the Nine Major Pharmaceutical

More information

REFERENCE CODE GDHC317DFR PUBLICAT ION DATE DECEMBER 2013 LUCENTIS (MICROVASCULAR COMPLICATIONS OF DIABETES) - FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC317DFR PUBLICAT ION DATE DECEMBER 2013 LUCENTIS (MICROVASCULAR COMPLICATIONS OF DIABETES) - FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC317DFR PUBLICAT ION DATE DECEMBER 2013 LUCENTIS Executive Summary The table below presents a summary of the key metrics for Lucentis (Microvascular Complications for Diabetes) for recombinant

More information

Country Coverage. Company Coverage

Country Coverage. Company Coverage Global Heart Valve Devices Market: Analysis By Procedure (Replacement & Repair), Replacement Procedure By Technique (Mechanical, Bioprosthetic & TAVR), Repair Procedure By Technique (Surgical, Balloon

More information

REFERENCE CODE GDME0188M AR PUBLICATION DATE FEBRUARY 2014 BIOPSY DEVICES - GLOBAL ANALYSIS AND MARKET FORECASTS

REFERENCE CODE GDME0188M AR PUBLICATION DATE FEBRUARY 2014 BIOPSY DEVICES - GLOBAL ANALYSIS AND MARKET FORECASTS REFERENCE CODE GDME0188M AR PUBLICATION DATE FEBRUARY 2014 BIOPSY DEVICES - Executive Summary The table below provides an overview of the global biopsy devices market during the forecast period from 2013

More information

REFERENCE CODE GDHC196DFR PUBLICAT ION DATE JUNE 2013 ABRAXANE (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC196DFR PUBLICAT ION DATE JUNE 2013 ABRAXANE (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC196DFR PUBLICAT ION DATE JUNE 2013 ABRAXANE (NON-SMALL CELL LUNG CANCER) Executive Summary Abraxane (nab-paclitaxel): Key Metrics in NSCLC Markets 2012 Abraxane Sales US 5EU $98.34m

More information

REFERENCE CODE GDHC519DFR PUBLICAT ION DATE DECEMBER 2014 LOTRONEX (IRRITABLE BOWEL SYNDROME) FORECAST AND MARKET ANALYSIS TO 2023

REFERENCE CODE GDHC519DFR PUBLICAT ION DATE DECEMBER 2014 LOTRONEX (IRRITABLE BOWEL SYNDROME) FORECAST AND MARKET ANALYSIS TO 2023 REFERENCE CODE GDHC519DFR PUBLICAT ION DATE DECEMBER 2014 LOTRONEX (IRRITABLE BOWEL SYNDROME) Executive Summary The Table below presents the key metrics of Prometheus Lotronex for irritable bowel syndrome

More information

Cyclokat (Dry Eye Syndrome)

Cyclokat (Dry Eye Syndrome) Cyclokat (Dry Eye Syndrome) Forecast and Market Analysis to 2022 GDHC191DFR / Published July 2013 Executive Summary Below table provides a summary of the key metrics for Cyclokat in the major pharmaceuticals

More information

REFERENCE CODE GDHC1174DFR PUBLICATION DATE M AY 2013

REFERENCE CODE GDHC1174DFR PUBLICATION DATE M AY 2013 REFERENCE CODE GDHC1174DFR PUBLICATION DATE M AY 2013 XELJANZ (PSORIASIS) - Executive Summary Table below presents key metrics for Xeljanz (tofacitinib) in seven of the nine major pharmaceutical markets

More information

Global Oil Softgel Capsules Market Research Report 2016

Global Oil Softgel Capsules Market Research Report 2016 Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Oil Softgel Capsules Market Research Report 2016 Global Oil Softgel Capsules Market Research Report 2016

More information

Sofosbuvir and Sofosbuvir/Ledipasvir (Hepatitis C Virus) Forecast and Market Analysis to GDHC1150DFR / Published May 2013

Sofosbuvir and Sofosbuvir/Ledipasvir (Hepatitis C Virus) Forecast and Market Analysis to GDHC1150DFR / Published May 2013 Sofosbuvir and Sofosbuvir/Ledipasvir (Hepatitis C Virus) Forecast and Market Analysis to 2022 GDHC1150DFR / Published May 2013 Executive Summary Sofosbuvir and Sofosbuvir/Ledipasvir: Key Metrics in Nine

More information

REFERENCE CODE GDHC518DFR PUBLICAT ION DATE DECEMBER 2014 LINZESS (IRRITABLE BOWEL SYNDROME) - FORECAST AND MARKET ANALYSIS TO 2023

REFERENCE CODE GDHC518DFR PUBLICAT ION DATE DECEMBER 2014 LINZESS (IRRITABLE BOWEL SYNDROME) - FORECAST AND MARKET ANALYSIS TO 2023 REFERENCE CODE GDHC518DFR PUBLICAT ION DATE DECEMBER 2014 LINZESS (IRRITABLE BOWEL SYNDROME) - Executive Summary The Table below presents the key metrics of Ironwood/Actavis/Almirall/Astellas Linzess for

More information

Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H2, 2015

Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H2, 2015 Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H2, 2015 Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H2, 2015 BioPortfolio

More information

BRIC DIABETES DRUGS MARKET

BRIC DIABETES DRUGS MARKET BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a

More information

REFERENCE CODE GDHC1114CFR PUBLICATION DATE M AY 2013

REFERENCE CODE GDHC1114CFR PUBLICATION DATE M AY 2013 REFERENCE CODE GDHC1114CFR PUBLICATION DATE M AY 2013 PSORIASIS - Psoriasis - India Drug Forecast and Market Analysis to Executive Summary Sales for Psoriasis in India 2012 We estimate the 2012 PsO drug

More information

REFERENCE CODE GDHC422DFR PUBLICAT ION DATE M AY 2014 BRINTELLIX (MAJOR DEPRESSIVE DISORDER) - FORECAST AND MARKET ANALYSIS TO 2023

REFERENCE CODE GDHC422DFR PUBLICAT ION DATE M AY 2014 BRINTELLIX (MAJOR DEPRESSIVE DISORDER) - FORECAST AND MARKET ANALYSIS TO 2023 REFERENCE CODE GDHC422DFR PUBLICAT ION DATE M AY 2014 BRINTELLIX (MAJOR DEPRESSIVE DISORDER) - Executive Summary Table below presents the key metrics for Brintellix in the seven major pharmaceutical markets

More information

Ultrasound Device Market - Industry Analysis, Size, Share, Growth and Forecasts to Hexa Research

Ultrasound Device Market - Industry Analysis, Size, Share, Growth and Forecasts to Hexa Research Ultrasound Device Market - Industry Analysis, Size, Share, Growth and Forecasts to 2024 - Hexa Research " The global ultrasound device market was valued at approximately USD 6.8 billion and it is projected

More information

REFERENCE CODE GDHC1013FPR PUBLICAT ION DATE AUGUST 2013 MENINGOCOCCAL VACCINES - CURRENT AND FUTURE PLAYERS

REFERENCE CODE GDHC1013FPR PUBLICAT ION DATE AUGUST 2013 MENINGOCOCCAL VACCINES - CURRENT AND FUTURE PLAYERS REFERENCE CODE GDHC1013FPR PUBLICAT ION DATE AUGUST 2013 MENINGOCOCCAL VACCINES - Executive Summary Meningococcal Vaccines: Key Metrics in the Nine Major Pharmaceutical Markets 2012 Epidemiology Targeted

More information

REFERENCE CODE GDHC471DFR PUBLICAT ION DATE NOVEM BER 2014 VECTIBIX (COLORECTAL CANCER) FORECAST AND MARKET ANALYSIS TO 2023

REFERENCE CODE GDHC471DFR PUBLICAT ION DATE NOVEM BER 2014 VECTIBIX (COLORECTAL CANCER) FORECAST AND MARKET ANALYSIS TO 2023 REFERENCE CODE GDHC471DFR PUBLICAT ION DATE NOVEM BER 2014 VECTIBIX (COLORECTAL CANCER) Executive Summary Table below presents the key metrics for Vectibix for colorectal cancer (CRC) in the eight major

More information

REFERENCE CODE GDHC472DFR PUBLICAT ION DATE NOVEM BER 2014 STIVARGA (COLORECTAL CANCER) FORECAST AND MARKET ANALYSIS TO 2023

REFERENCE CODE GDHC472DFR PUBLICAT ION DATE NOVEM BER 2014 STIVARGA (COLORECTAL CANCER) FORECAST AND MARKET ANALYSIS TO 2023 REFERENCE CODE GDHC472DFR PUBLICAT ION DATE NOVEM BER 2014 STIVARGA (COLORECTAL CANCER) Executive Summary Table below presents the key metrics for Stivarga for colorectal cancer (CRC) in the eight major

More information

eclinical Solutions Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research

eclinical Solutions Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research eclinical Solutions Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research " Projected to grow at a CAGR of around 12%, eclinical solutions market is expected to witness significant

More information

REFERENCE CODE GDHC207DFR PUBLICAT ION DATE JUNE 2013 GILOTRIF (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022

REFERENCE CODE GDHC207DFR PUBLICAT ION DATE JUNE 2013 GILOTRIF (NON-SMALL CELL LUNG CANCER) FORECAST AND MARKET ANALYSIS TO 2022 REFERENCE CODE GDHC207DFR PUBLICAT ION DATE JUNE 2013 GILOTRIF (NON-SMALL CELL LUNG CANCER) GILOTRIF (NON-SMALL CELL LUNG CANCER) - Executive Summary Gilotrif: Key Metrics in NSCLC Markets 2022 Gilotrif

More information

Sickle-cell Anemia Therapeutics Market in the US

Sickle-cell Anemia Therapeutics Market in the US Sickle-cell Anemia Therapeutics Market in the US 2015-2019 Sickle-cell Anemia Therapeutics Market in the US 2015-2019 Sector Publishing Intelligence Limited (SPi) has been marketing business and market

More information